News BioMarin halts Voxzogo trials due to safety signal BioMarin has suspended dosing in phase 2 trials of its achondroplasia therapy Voxzogo aimed at broadening the drug's label.
News US judge rules Kennedy's vaccine changes 'unlawful' A US judge has stymied attempts by HHS Secretary Kennedy to change immunisation policy, stopping this week's vaccine advisory panel from going ahead.
News Denying prostate cancer screening 'no longer rational' A German study has stoked debate about the merits of screening for prostate cancer, which is lagging behind breast cancer screening in Europe.
News NHS hospitals 'should resist Palantir software rollout' Hospitals in England have been told they do not have to deploy a controversial Palantir data platform by a coalition led by healthcare charity Medact.
News Poll finds Americans cutting back elsewhere to fund health Many Americans are forced to make difficult trade-offs with living expenses and delay life events like retirement to afford health, says a new poll.
News Novo rapped by FDA for not reporting drug adverse effects Novo Nordisk has been sent a warning letter from the FDA for violations of postmarketing adverse drug experience (PADE) regulations.
Digital Trustworthy and novel AI in clinical trial planning, with Kr... Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
